STOCKHOLM — New data on a needle-free nasal delivery system for glucagon for use in severe hypoglycemia presented at the European Association for the Study of Diabetes (EASD) 2015 Meeting here ...

This work was recently published in Stem Cell Reports. These stem cell-derived alpha cells very closely resembled pancreas-derived alpha cells and secreted comparable levels of glucagon.

CRYSTAL LAKE, Ill., July 23, 2025--New Study Using Aptar’s Nasal Drug Delivery System Validates Insulin Nasal Spray to Deliver Alzheimer’s Drug Directly to the Brain ...